Island Pharmaceuticals granted key patent for ISLA-101 in the United States

  • Island's lead asset, ISLA-101 granted key patent from United Stated Patent & Trademark Office
  • Patent underpins Island's drug repurposing strategy to rapidly and efficiently develop antiviral therapies with a key focus being mosquito borne viral diseases, such as dengue fever.
  • Around 390 million people are infected with dengue fever each year[1]...

Read more: Island Pharmaceuticals granted key patent for ISLA-101 in the United States

More Articles …

  1. e.GO reaches agreement for market entry in Mexico
  2. Vestas completes the construction of Western Australia's biggest wind farm and will provide its service and maintenance for the next 25 years
  3. Adani Green Energy to acquire SB Energy's 5 GW India renewable power portfolio for a fully completed EV of USD 3.5 billion - India's largest renewables M&A transaction
  4. AvePoint Assessed Against Official IRAP Controls, Demonstrating its Longstanding Commitment to Security for Government Entities
  5. Megaport Virtual Edge, Megaport's On-demand NFV Service, Brings Branch-to-Cloud Connectivity to Fortinet Secure SD-WAN Customers
  6. LINK Mobility Goes Global
  7. Sigmax.io introduces an innovative trading bot that simplifies arbitrage trading
  8. Hoist Finance Selects LTI's Digital Banking Platform to Achieve Accelerated Growth in Europe
  9. 500 CEOs of major organisations create the world's biggest community for disability business inclusion - The Valuable 500
  10. The Launch of Crurated, a New Membership-Based Wine Community